ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-14 Cr | ₹17 Cr | ₹-19 Cr | ₹18 Cr | ₹-11 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ORCHID PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-14 Cr |
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹-11 Cr |
How is Net Cash Inflow / Outflow of ORCHID PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-14 Cr | Negative | |
| Mar2025 | ₹17 Cr | Positive | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹18 Cr | Positive | |
| Mar2022 | ₹-11 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,196.0 Cr | 2.5% | -15.4% | 24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 2.5% |
-15.4% |
24.4% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses